136 related articles for article (PubMed ID: 22321906)
21. Fertility Sparing Surgery and Borderline Ovarian Tumours.
Kasaven LS; Chawla M; Jones BP; Al-Memar M; Galazis N; Ahmed-Salim Y; El-Bahrawy M; Lavery S; Saso S; Yazbek J
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326636
[TBL] [Abstract][Full Text] [Related]
22. Develop a nomogram to predict overall survival of patients with borderline ovarian tumors.
Gong XQ; Zhang Y
World J Clin Cases; 2022 Mar; 10(7):2115-2126. PubMed ID: 35321187
[TBL] [Abstract][Full Text] [Related]
23. Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.
Ogrodniczak A; Menkiszak J; Gronwald J; Tomiczek-Szwiec J; Szwiec M; Cybulski C; Dębniak T; Huzarski T; Tołoczko-Grabarek A; Byrski T; Białkowska K; Prajzendanc K; Baszuk P; Lubiński J; Jakubowska A
Hered Cancer Clin Pract; 2022 Mar; 20(1):11. PubMed ID: 35313928
[TBL] [Abstract][Full Text] [Related]
24. Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China.
He P; Wang JJ; Duan W; Song C; Yang Y; Wu QQ
J Ovarian Res; 2021 Dec; 14(1):169. PubMed ID: 34857005
[TBL] [Abstract][Full Text] [Related]
25. Serous Borderline Ovarian Tumor Diagnosis, Management and Fertility Preservation in Young Women.
Carbonnel M; Layoun L; Poulain M; Tourne M; Murtada R; Grynberg M; Feki A; Ayoubi JM
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575343
[TBL] [Abstract][Full Text] [Related]
26. Cytology of peritoneal implants of borderline serous tumor of ovaries in ascitic fluid.
Sharma S; Mohapatra DS; Gupta N; Srinivasan R; Rajwanshi A; Dey P
Cytojournal; 2021; 18():17. PubMed ID: 34512788
[TBL] [Abstract][Full Text] [Related]
27. Risk factors that increase recurrence in borderline ovarian cancers.
Birge O; Bakır MS; Karadag C; Dinc C; Doğan S; Tuncer HA; Simsek T
Am J Transl Res; 2021; 13(7):8438-8449. PubMed ID: 34377341
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Factors Influencing Relapse and Pregnancy in Patients with Borderline Ovarian Tumors.
Qi Y; Wang M; Yang Y; Zeng Z; Zhou Y
J Cancer; 2021; 12(17):5275-5285. PubMed ID: 34335944
[No Abstract] [Full Text] [Related]
29. Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group.
Lecointre L; Bund V; Sangnier E; Ouldamer L; Bendifallah S; Koskas M; Bolze PA; Collinet P; Canlorbe G; Touboul C; Huchon C; Coutant C; Faller E; Boisramé T; Gantzer J; Demarchi M; Lavoué V; Akladios C
Ann Surg Oncol; 2021 Nov; 28(12):7616-7623. PubMed ID: 33904003
[TBL] [Abstract][Full Text] [Related]
30. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
Wang P; Fang L
World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
[TBL] [Abstract][Full Text] [Related]
31. Assessment of different NEoplasias in the adneXa model for differentiation of benign and malignant adnexal masses in Korean women.
Nam G; Lee SR; Jeong K; Kim SH; Moon HS; Chae HD
Obstet Gynecol Sci; 2021 May; 64(3):293-299. PubMed ID: 33593045
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.
Hada T; Miyamoto M; Ishibashi H; Kawauchi H; Soyama H; Matsuura H; Sakamoto T; Kakimoto S; Aoyama T; Iwahashi H; Suzuki R; Tsuda H; Takano M
In Vivo; 2020; 34(3):1341-1346. PubMed ID: 32354928
[TBL] [Abstract][Full Text] [Related]
33. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
34. Recurrence rate and associated factors of borderline ovarian tumors in the south of Vietnam.
Vo TM; Duong KA; Tran LT; Bui TC
J Obstet Gynaecol Res; 2019 Oct; 45(10):2055-2061. PubMed ID: 31368150
[TBL] [Abstract][Full Text] [Related]
35. RETROSPECTIVE ANALYSIS OF BORDERLINE OVARIAN TUMORS: OUTCOMES AT A SINGLE CENTER.
Yilmaz E; Sahin N; Koleli I; Melekoglu R; Tanrikut E; Faydali S; Karaer A; Coskun EI
Acta Clin Croat; 2019 Mar; 58(1):29-36. PubMed ID: 31363322
[TBL] [Abstract][Full Text] [Related]
36. Tumors of low malignant potential a single institution experience.
Jbir I; Ghalleb M; Triki A; Zemni I; Hechiche M; Ben Hassouna J; Rahal K
Int J Surg Case Rep; 2019; 55():41-46. PubMed ID: 30684818
[TBL] [Abstract][Full Text] [Related]
37. Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological Malignancies.
Perrone AM; Girolimetti G; Procaccini M; Marchio L; Livi A; Borghese G; Porcelli AM; De Iaco P; Gasparre G
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011887
[TBL] [Abstract][Full Text] [Related]
38. The safety of fertility and ipsilateral ovary procedures for borderline ovarian tumors.
Lou T; Yuan F; Feng Y; Wang S; Bai H; Zhang Z
Oncotarget; 2017 Dec; 8(70):115718-115729. PubMed ID: 29383195
[TBL] [Abstract][Full Text] [Related]
39. Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis.
Zhou Z; Zeng F; Yuan J; Tang J; Colditz GA; Tworoger SS; Trabert B; Su X
Cancer Causes Control; 2017 May; 28(5):415-428. PubMed ID: 28342087
[TBL] [Abstract][Full Text] [Related]
40. Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study.
Gokcu M; Gungorduk K; Aşıcıoğlu O; Çetinkaya N; Güngör T; Pakay G; Cüylan ZF; Toptaş T; Özyurt R; Ağaçayak E; Ozdemir A; Erol O; Turan A; Gülseren V; İcen MS; Şenol T; Güraslan H; Yücesoy B; Sahbaz A; Gungorduk O; Besimoğlu B; Pakay K; Temizkan O; Sancı M; Şimşek T; Meydanlı MM; Harma M; Yaşar L; Boran B; Uysal AD; Karateke A
J Ovarian Res; 2016 Oct; 9(1):66. PubMed ID: 27756415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
